Literature DB >> 3799813

Tumor necrosis factor production by human sarcoid alveolar macrophages.

P R Bachwich, J P Lynch, J Larrick, M Spengler, S L Kunkel.   

Abstract

Tumor necrosis factor (TNF) is an oncolytic peptide that may also exert many other biologic effects. Experimentally, immunologically activated mononuclear phagocytes stimulated with endotoxin (LPS) produce TNF, while resting mononuclear phagocytes stimulated with LPS produce little TNF. To date, the ability of human alveolar macrophages (AMs) to produce TNF has not been clearly delineated. As pulmonary sarcoidosis is a granulomatous inflammatory disorder characterized by immunologically activated AMs, we investigated the production of TNF by AMs obtained by bronchoalveolar lavage from 7 normal volunteers and 13 patients with pulmonary sarcoidosis. The AMs were cultured with and without LPS, and TNF production was assessed by an in vitro cytotoxicity assay. Unstimulated sarcoid and normal AMs produced little TNF, but LPS stimulation enhanced TNF production by both normal and sarcoid AMs. Furthermore, LPS-stimulated sarcoid AMs produced more TNF than normal AMs (84.9 +/- 16.7 versus 32.5 +/- 10.2 units/million cells, P less than 0.05). It is concluded that human AMs can produce TNF and that sarcoid AMs are primed and can produce significantly more TNF, compared with normal AMs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3799813      PMCID: PMC1888469     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

Authors:  D R Bertolini; G E Nedwin; T S Bringman; D D Smith; G R Mundy
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

2.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

4.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Tumor necrosis factor (TNF).

Authors:  L J Old
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

6.  Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.

Authors:  G E Nedwin; L P Svedersky; T S Bringman; M A Palladino; D V Goeddel
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

7.  Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages.

Authors:  P R Bachwich; S W Chensue; J W Larrick; S L Kunkel
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

8.  Rabbit tumor necrosis factor: mechanism of action.

Authors:  M R Ruff; G E Gifford
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

Authors:  J Vilcek; V J Palombella; D Henriksen-DeStefano; C Swenson; R Feinman; M Hirai; M Tsujimoto
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  36 in total

Review 1.  Bronchoalveolar lavage and the immunology of lung cancer.

Authors:  G Semenzato; M Spatafora; C Feruglio; E Pace; V Dipietro
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Immune responses in the lung: basic principles.

Authors:  C Agostini; G Semenzato
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders.

Authors:  K Packwood; E Drewe; E Staples; D Webster; T Witte; J Litzman; W Egner; R Sargur; W Sewell; E Lopez-Granados; S L Seneviratne; R J Powell; B L Ferry; H M Chapel
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

4.  Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis.

Authors:  I Bäumer; G Zissel; M Schlaak; J Müller-Quernheim
Journal:  Lung       Date:  1997       Impact factor: 2.584

5.  Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice.

Authors:  G Sakuntala Warshamana; Derek A Pociask; Krishna J Fisher; Jing-Yao Liu; Patricia J Sime; Arnold R Brody
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

6.  Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats.

Authors:  P D McGavran; L B Moore; A R Brody
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

7.  Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

Authors:  C Ferran; F Dautry; S Mérite; K Sheehan; R Schreiber; G Grau; J F Bach; L Chatenoud
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation.

Authors:  Y Shikama; K Kobayashi; K Kasahara; S Kaga; M Hashimoto; I Yoneya; S Hosoda; K Soejima; H Ide; T Takahashi
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

9.  Inhibitory effects of inhaled flunisolide on inflammatory functions of alveolar macrophages.

Authors:  B Bewig; J Barth
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Expression of the CD11/CD18 cell surface adhesion glycoprotein family and MHC class II antigen on blood monocytes and alveolar macrophages in interstitial lung diseases.

Authors:  H C Hoogsteden; P T van Hal; J M Wijkhuijs; W Hop; C Hilvering
Journal:  Lung       Date:  1992       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.